Dr. Leopold is a Senior Research Fellow in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute, Division of Health Policy and Insurance Research. Her research focuses on providing evidence on access to and affordability of medicines by examining the economic burden of cancer treatments, by comparing countries’ medicine pricing and reimbursement policies and by assessing patients’ and providers’ perceptions on value measures in cancer care. She feels passionate about bridging health policy and care delivery by tackling ethical considerations of priority setting in health care.
She recently received grant funding from the Department of Population Medicine to look at patients’ and providers’ perspectives on value-frameworks for cancer treatments within the Harvard Pilgrim Health Care population. Further, she works on various large-scale claims analyses in which she assesses the impact of policy changes (regulatory or coverage) on utilization, out-of-pocket spending and costs of metastatic breast cancer. In addition, Dr. Leopold works on assessing countries’ approaches of incorporating societal perspectives into coverage decisions. Finally, she coordinates the Thematic Working Group on Medicines in Health Systems of Health Systems Global.
Prior to joining the Department of Population Medicine, she worked as a senior researcher at the Austrian Health Institute, Department of Health Economics / WHO Collaborating Center for Pharmaceutical Pricing and Reimbursement Policies, where she co-led the Austrian Centre for Rare Diseases as well as the European Network of public authorities of Pharmaceutical Pricing and Reimbursement Information (PPRI). She holds a doctorate in Pharmaceutical Policy from Utrecht University, Utrecht Institute for Pharmaceutical Science / WHO Collaborating Centre for Pharmaceutical Policy and Regulation in the Netherlands and a Master of Science degree from Bocconi University in Italy.